相关实验视频

Updated: Jul 22, 2026

Characterization of Human Monocyte-derived Dendritic Cells by Imaging Flow Cytometry: A Comparison between Two Monocyte Isolation Protocols

Characterization of Human Monocyte-derived Dendritic Cells by Imaging Flow Cytometry: A Comparison between Two Monocyte Isolation Protocols

Published on: October 18, 2016

前列腺癌患者中受损的单细胞衍生的树突细胞表型:与健康捐赠者的表型比较

Parisa Bakhshi¹, Maryam Nourizadeh², Laleh Sharifi³

¹Department of Medical Biotechnology, School of Allied Medical Sciences, Iran University of Medical Sciences, Tehran, Iran.

Cancer reports (Hoboken, N.J.)

|February 14, 2024

概括

来自前列腺癌患者的单细胞衍生的树突细胞 (Mo-DCs) 显示出受损的特征,影响癌症疫苗的疗效. 需要策略来增强Mo-DC功能,以获得更好的免疫治疗结果.

科学领域:

免疫学免疫学免疫学
癌症研究癌症研究
细胞生物学细胞生物学

背景情况:

树突细胞 (DCs) 对于免疫反应至关重要.
单细胞衍生的DCs (Mo-DCs) 正在为癌症疫苗探索,但临床成功是有限的.
这项研究调查了前列腺癌 (PCA) 患者与健康捐赠者的Mo-DCs.

研究的目的:

为了比较来自前列腺癌患者和健康捐赠者的Mo-DCs的表型特征.
为了确定基于Mo-DC的癌症疫苗有限成功的潜在原因.

主要方法:

从PCA患者和健康的捐赠者中分离单细胞.
对Mo-DCs的表型分析,评估单细胞计数和CD14表达.
对DC成熟标记物的量化:HLA-DR,CD80和CD86.

主要成果:

与健康捐献者相比,PCA患者样本的单细胞计数和CD14表达明显较低.
与健康的供体DC相比,PCA患者的Mo-DCs表现出成熟标志物的表达减少 (HLA-DR,CD80,CD86).
单细胞计数和CD14表达的统计学意义被观察到 (p < 0.0001).

结论:

来自PCA患者的Mo-DCs表型特征受损可能会阻碍癌症疫苗的有效性.
癌症患者的低最佳Mo-DC特征导致临床试验的成功有限.
需要采用替代策略来改善Mo-DC功能,以增强癌症免疫疗法.

关键词:

具有共同刺激性的分子.树突细胞是一种树突细胞.前列腺癌是前列腺癌.

更多相关视频

Generation of Human Monocyte-derived Dendritic Cells from Whole Blood

Generation of Human Monocyte-derived Dendritic Cells from Whole Blood

Published on: December 24, 2016

Author Spotlight: Dendritic Cells Maturation Using Sialidases-Based Enzymatic Treatment of the Cell Surface

Author Spotlight: Dendritic Cells Maturation Using Sialidases-Based Enzymatic Treatment of the Cell Surface

Published on: October 20, 2023

相关概念视频

Bone Marrow Sampling and Transplants

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...

Tissue Transplantation

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...

Kidney Transplant I: Introduction

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...